SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Chiasma, Inc. and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / July 29, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against Chiasma, Inc. (“Chiasma” or the “Company”) (NASDAQ: CHMA). Investors who purchased or otherwise acquired shares between July 15, 2015 and April 17, 2016, inclusive (the “Class Period”), are encouraged to contact the Firm prior to the August
8, 2016, lead plaintiff motion deadline.

If you purchased shares of Chiasma during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that the Company made materially false and/or misleading statements about its business during the Class Period. The Company failed to disclose that the Phase 3 clinical trial for its oral octreotide, Mycapssa, which was conducted before the July 15, 2015 IPO, was insufficient to prove efficacy and secure FDA approval. In addition, Chiasma’s supervision of its suppliers was not sufficient to prevent deficiencies that delayed FDA approval of Mycapssa. On April 18, 2016, the Company announced that the FDA issued a Complete Response Letter in response to the Company’s New Drug Application for Mycapssa, stating that the FDA did not believe the application provided sufficient evidence of efficacy to warrant approval and another clinical trial would be necessary, and that deficiencies with the Company’s suppliers would need to be resolved. When Chiasma disclosed this news on April 18, 2016, the share price fell 63.13% on that day.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 443011